GSK To Make Available Rotavirus Vaccine, Rotarix To Gavi Alliance At $2.50 Per Dosage GSK declared that it has made a new proposal to make available its rotavirus vaccine, Rotarix, to the Gavi Alliance at $2.50 per dosage, a small portion of developed world prices. This pronouncement is part of the company’s labors to enhance access to its medicines and vaccines in the poorest countries of the world. It is expected that more than half a million children die of rotavirus gastroenteritis each year – the equivalent...